Group 1 - The article highlights the successful implementation of the world's first robot-assisted dual Augment (Footing) hip acetabular repair total hip replacement surgery by the orthopedic team at Hong Kong's Alice Ho Miu Ling Nethersole Hospital, led by Dr. Cai Zilong [1][3] - The surgery utilized the Kuntuo orthopedic surgical robot, which was developed by Yuanhua Intelligent, to address a complex case involving severe bone defects in the acetabulum, marking a significant breakthrough in robot-assisted orthopedic surgery for challenging joint reconstruction [1][3] - The innovative "Footing prosthesis" reconstruction plan was introduced, which significantly improves bone coverage and restores the center of joint rotation to its physiological position, fundamentally ensuring the long-term survival rate of the prosthesis [3][7] Group 2 - The patient was an elderly individual suffering from severe hip joint pain and functional impairment, with imaging revealing rare dual-region bone defects in the acetabulum, making traditional surgical methods inadequate [3] - The Kuntuo robot's advanced capabilities in sub-millimeter 3D reconstruction, intelligent planning, and real-time navigation enabled the surgical team to create a customized "Footing prosthesis" by combining two Augment modules, achieving a precise fit [3][7] - The successful surgery is seen as a perfect combination of advanced robotic technology and innovative clinical thinking, providing unprecedented certainty and capability for complex reconstruction surgeries [7] Group 3 - The hospital administration praised the milestone significance of the surgery, stating it opens new treatment pathways for complex hip joint diseases and showcases the hospital's leading strength in integrating cutting-edge medical technology [7] - The Kuntuo robot, which has received approval from the National Medical Products Administration (NMPA), is the world's first five-in-one orthopedic surgical robot, capable of addressing multiple indications including total knee, total hip, unicompartmental, spine, and trauma surgeries [7] - The success of the first "dual Augment" surgery further confirms the robot's strong adaptability and clinical value in complex orthopedic scenarios, injecting strong momentum for Chinese original high-end medical equipment to enter the global stage [7]

Core Viewpoint - The article highlights the successful implementation of the world's first robot-assisted dual Augment (Footing) hip acetabulum repair total hip replacement surgery at the Hong Kong Aesthetic Hospital, showcasing a significant breakthrough in robotic-assisted orthopedic surgery for complex joint reconstruction [1][3]. Group 1: Surgical Innovation - The surgery was performed on an elderly patient suffering from severe hip joint pain and functional impairment, with imaging revealing rare dual-region bone defects in the acetabulum [3]. - Traditional surgical methods were inadequate for addressing both prosthetic stability and anatomical restoration, prompting the surgical team to innovate a customized "Footing prosthesis" using two Augment modules [3]. - The use of the Kuan robot enabled precise sub-millimeter 3D reconstruction, intelligent planning, and real-time navigation, allowing for a tailored solution that significantly improved bone coverage and restored the joint's rotational center to its physiological position [3][5]. Group 2: Technological Impact - The successful surgery exemplifies the perfect combination of advanced robotic technology and innovative clinical thinking, providing unprecedented certainty and capability in complex reconstruction surgeries [5]. - The Kuan robot, approved by the National Medical Products Administration (NMPA), is the world's first five-in-one orthopedic surgical robot, capable of addressing multiple indications including total knee, total hip, unicompartmental, spinal, and trauma surgeries [5]. - This milestone not only opens new treatment pathways for patients with complex hip joint diseases but also highlights the hospital's leading capabilities in integrating cutting-edge medical technology to enhance the treatment of difficult cases [5].

Core Viewpoint - Tianzhihang (688277) is actively pursuing an overseas expansion strategy, showcasing its technological innovations and product offerings at international exhibitions, and has achieved CE certification for its orthopedic surgical navigation system, laying the groundwork for entering overseas markets [1][3]. Group 1: Company Performance - As of October 17, 2025, Tianzhihang's stock closed at 17.53 yuan, down 2.77% from the previous week [1]. - The company has maintained the largest market share in the domestic orthopedic robot market, with a significant increase in bidding activity, showing over 50% year-on-year growth in orthopedic robot tenders [1][3]. Group 2: Technological Advancements - Since 2006, the company has been a pioneer in remote orthopedic robotic surgery, completing over 1,000 remote surgeries across 24 provinces and municipalities, establishing 5G remote surgery as a standard practice [2][3]. - The company has received approval for robotic-assisted orthopedic surgery in over 20 provinces and cities, with Beijing including it in its medical insurance payment directory [2][3]. Group 3: Corporate Governance - The second extraordinary general meeting of shareholders was held on October 16, 2025, with 203 shareholders present, representing 36.03% of the voting shares [3][4]. - The meeting approved the increase of the estimated amount for daily related transactions and the re-election of a non-independent director, with no proposals being rejected [3][4].